These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9145287)

  • 41. Guidelines, pathways, bundles, and protocols: clinical recipes for success.
    Betit P
    Respir Care; 2015 Mar; 60(3):469-70. PubMed ID: 25737573
    [No Abstract]   [Full Text] [Related]  

  • 42. Growth hormone does not prevent catabolic side effects of dexamethasone in extremely low birth weight preterm infants with bronchopulmonary dysplasia--a pilot study.
    Tonini G; Pahor T; Colonna F; de Vonderweid U
    J Pediatr Endocrinol Metab; 1997; 10(3):291-4. PubMed ID: 9388821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled nitric oxide and oral nifedipine in a preterm infant with bronchopulmonary dysplasia and pulmonary hypertension.
    Rosati E; Butera G; Bossone E; De Felice C; Latini G
    Eur J Pediatr; 2007 Jul; 166(7):737-8. PubMed ID: 17103192
    [No Abstract]   [Full Text] [Related]  

  • 44. Pathogenesis of bronchopulmonary dysplasia.
    Hayes D; Feola DJ; Murphy BS; Shook LA; Ballard HO
    Respiration; 2010; 79(5):425-36. PubMed ID: 19786727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surfactant, steroids and non-invasive ventilation in the prevention of BPD.
    Dumpa V; Bhandari V
    Semin Perinatol; 2018 Nov; 42(7):444-452. PubMed ID: 30343941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of lung surfactant therapy on chronic lung diseases in premature infants.
    Hudak BB; Egan EA
    Clin Perinatol; 1992 Sep; 19(3):591-602. PubMed ID: 1526073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The combined effect of prenatal steroid prophylaxis, neonatal surfactant therapy and reduction of risk of complications from respiratory life support on survival rate of very low birthweight infants].
    Görbe E; Jeager J; Kohalmi B; Patkós P; Cziniel M; Sassi L
    Orv Hetil; 2004 Jun; 145(23):1227-32. PubMed ID: 15264590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
    Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC
    Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antenatal exposure to Ureaplasma species exacerbates bronchopulmonary dysplasia synergistically with subsequent prolonged mechanical ventilation in preterm infants.
    Inatomi T; Oue S; Ogihara T; Hira S; Hasegawa M; Yamaoka S; Yasui M; Tamai H
    Pediatr Res; 2012 Mar; 71(3):267-73. PubMed ID: 22258085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxygen consumption in infants with bronchopulmonary dysplasia.
    Rozé JC; Darmaun D; Gaultier C
    Pediatr Pulmonol Suppl; 1997; 16():172-3. PubMed ID: 9443259
    [No Abstract]   [Full Text] [Related]  

  • 52. Bronchopulmonary dysplasia in preterm infants managed with non-invasive ventilation or surfactant and a brief period of mechanical ventilation: a 6-year cohort study.
    König K; Guy KJ
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):608-11. PubMed ID: 23834679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Feeding problems in infants with bronchopulmonary dysplasia and other chronic respiratory disorders].
    van Wezel-Meijler G; Karperien A; Cats BP; Wauters EA
    Tijdschr Kindergeneeskd; 1990 Apr; 58(2):73-8. PubMed ID: 2349562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal Caffeine Treatment and Respiratory Function at 11 Years in Children under 1,251 g at Birth.
    Doyle LW; Ranganathan S; Cheong JLY
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1318-1324. PubMed ID: 28707987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Neonatal colonization by Ureaplasma urealyticum and the development of bronchopulmonary dysplasia].
    Acosta B; Morcillo F; Viudes A; Gascó B; González C; Roqués V; Gobernado M
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):493-7. PubMed ID: 10650644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Animal models of bronchopulmonary dysplasia. The preterm baboon models.
    Yoder BA; Coalson JJ
    Am J Physiol Lung Cell Mol Physiol; 2014 Dec; 307(12):L970-7. PubMed ID: 25281639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unusual pulmonary reaction to respiratory therapy in a premature newborn.
    McKay CA; Faulkner CS; Edwards WH
    Hum Pathol; 1985 Jun; 16(6):629-31. PubMed ID: 3997140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Home management of bronchopulmonary dysplasia].
    Lombet J
    Arch Pediatr; 1998 Apr; 5(4):442-8. PubMed ID: 9759168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lung injury and bronchopulmonary dysplasia in newborn infants.
    Christou H; Brodsky D
    J Intensive Care Med; 2005; 20(2):76-87. PubMed ID: 15855220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pathogenic factors in bronchopulmonary dysplasia].
    Figueras Aloy J; Vilanova Juanola JM; Molina González J; Jiménez González R
    An Esp Pediatr; 1991 Jul; 35(1):36-40. PubMed ID: 1772170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.